Hơn 300 chữ ký kêu gọi Gilead mở rộng sản xuất thuốc lenacapavir điều trị HIV

Trong thư gửi Gilead, hơn 300 người có tầm ảnh hưởng cho rằng nếu tất cả những người sống chung với AIDS được tiếp cận lenacapavir thì mối đe dọa sức khỏe toàn cầu này có thể kết thúc vào năm 2030.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Bộ Y tế: Thu hồi toàn quốc 162 sản phẩm mỹ phẩm vi phạm của Mailisa

Bộ Y tế: Thu hồi toàn quốc 162 sản phẩm mỹ phẩm vi phạm của Mailisa

Thuốc - Dinh dưỡng
Cục Quản lý Dược (Bộ Y tế) vừa ban hành quyết định thu hồi số tiếp nhận Phiếu công bố, đồng thời đình chỉ lưu hành, thu hồi toàn quốc hơn 160 sản phẩm mỹ phẩm vi phạm của Công ty Trách nhiệm hữu hạn Sản xuất Thương mại Dịch vụ Xuất nhập khẩu MK Skincare còn hạn sử dụng (đây...
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh